Opioid Crisis
Paid to Show the Drug Works: Why “Blind” Clinical Trials for New Drugs are Far Less Blind Than They Should Be
New research shows that physicians in industry-sponsored trials are more captured by pharmaceutical companies than physicians in unsponsored ones.
Economists love health care because it...
The Rise of the Opioids: How Purdue Invented New Markets for OxyContin
Purdue's strategy was to market its opioids directly to patients via brochures, videos, advertisements, and the internet. It also provided information to doctors and...
Editors’ Briefing: On Our Radar This Week (Feb. 24–March 3)
This week in political economy.
Italy’s elections are on Sunday, and with the polls being inconclusive and the reemergence of former PM Silvio Berlusconi...
Editors’ Briefing: On Our Radar This Week (Feb. 17–Feb. 24)
This week in political economy.
Is the US economy being strangled by a lack of competition? In the Harvard Business Review, David Wessel provides...
